The novel approach of the medication represents a significant breakthrough in the management of the condition. Unlike existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide313547.azzablog.com/42456667/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment